Holen Sie sich die Stockscreener-App
6.43
1.90%
0.12
Schlusskurs vom Vortag:
$6.31
Offen:
$6.4
24-Stunden-Volumen:
4,201
Relative Volume:
0.16
Marktkapitalisierung:
$9.83M
Einnahmen:
$22.03M
Nettoeinkommen (Verlust:
$-19.91M
KGV:
-0.3473
EPS:
-18.5136
Netto-Cashflow:
$-16.84M
1W Leistung:
+0.63%
1M Leistung:
-13.11%
6M Leistung:
-24.70%
1J Leistung:
-68.48%
1-Tages-Spanne:
$6.30
$6.54
1-Wochen-Bereich:
$6.08
$6.645
52-Wochen-Spanne:
$4.14
$21.78
Lifeward Ltd Stock (LFWD) Company Profile
Firmenname
Lifeward Ltd
Sektor
Branche
Telefon
15082511154
Adresse
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.43 | 9.64M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
102.50 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.94 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.45 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.55 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.00 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Eingeleitet | Laidlaw | Buy |
| 2017-04-03 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Eingeleitet | Oppenheimer | Outperform |
| 2016-07-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-05-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Bestätigt | Barclays | Equal Weight |
| 2014-10-07 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Lifeward Ltd Aktie (LFWD) Neueste Nachrichten
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - TipRanks
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - in.investing.com
Lifeward regains Nasdaq compliance after audit committee appointments - Investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - stocktitan.net
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - stocktitan.net
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - stocktitan.net
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - stocktitan.net
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - stocktitan.net
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - stocktitan.net
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - stocktitan.net
Lifeward adds biotech drug-delivery tech and taps up to $47M - stocktitan.net
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward Successfully Closes on Strategic Partnership with Oramed - Bitget
Lifeward Ltd. completed the acquisition of Oratech Pharma, Inc. from Oramed Pharmaceuticals Inc.. - marketscreener.com
If You Invested $1,000 in Lifeward Ltd (LFWD) - stocktitan.net
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - TradingView
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - gurufocus.com
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Lifeward Q4 2025 Earnings Call Transcript - MarketBeat
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Finanzdaten der Lifeward Ltd-Aktie (LFWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifeward Ltd-Aktie (LFWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jasinski Lawrence J | Chief Executive Officer |
May 21 '25 |
Sale |
1.26 |
1,909 |
2,405 |
98,728 |
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):